To gain initial insights into the possible modulation of the CTD code by Rho signaling in human cells, we used the relatively specific inhibitors for RhoA, Rac and Cdc42 in two human cancer cell lines: the prostate cancer DU145 cell line, and the cervical carcinoma HeLa cell line. The gene discussed is CDC42; the disease is prostate cancer.